Price Drop Reshapes Obesity Market
3:28–4:21 · 53s
He highlights surging sales of Mounjaro and Zepbound, then flags a sharp price decline—from around $1,000 to as low as $149 a month—that could dampen revenue and shrink market forecasts.
3:28–4:21 · 53s
He highlights surging sales of Mounjaro and Zepbound, then flags a sharp price decline—from around $1,000 to as low as $149 a month—that could dampen revenue and shrink market forecasts.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.